NewEdge Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
2,722
-690
-20% -$173K ﹤0.01% 1879
2025
Q4
$970K Buy
3,412
+798
+31% +$250K ﹤0.01% 1510
2025
Q3
$807K Buy
2,614
+1,542
+144% +$483K ﹤0.01% 1531
2025
Q2
$337K Buy
1,072
+865
+418% +$250K ﹤0.01% 1946
2025
Q1
$54.4K Buy
207
+64
+45% +$17.3K ﹤0.01% 2531
2024
Q4
$37.3K Hold
143
﹤0.01% 2623
2024
Q3
$33.3K Sell
143
-185
-56% -$38K ﹤0.01% 2559
2024
Q2
$66.2K Sell
328
-1
-0.3% -$180 ﹤0.01% 2254
2024
Q1
$56.4K Buy
329
+207
+170% +$38.6K ﹤0.01% 2267
2023
Q4
$26.5K Buy
122
+54
+79% +$9.26K ﹤0.01% 2467
2023
Q3
$10.8K Sell
68
-835
-92% -$187K ﹤0.01% 2549
2023
Q2
$260K Sell
903
-22
-2% -$6.68K ﹤0.01% 1517
2023
Q1
$295K Buy
925
+360
+64% +$107K ﹤0.01% 1383
2022
Q4
$150K Buy
+565
New +$156K ﹤0.01% 1282

Other funds holding PODD

NewEdge Advisors's PODD Position: Q1 2026 in Review

NewEdge Advisors reduced its Insulet (PODD) stake by 20% in Q1 2026, selling an estimated $173K and leaving 2,722 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

NewEdge Advisors first reported a position in PODD in Q4 2022 and has held it in 14 quarters since. The position peaked at $970K in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • NewEdge Advisors held 2,722 shares of Insulet worth $571K as of Q1 2026.
  • NewEdge Advisors sold 690 Insulet shares in Q1 2026, an estimated $173K.
  • Insulet made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1879 holding.
  • NewEdge Advisors first reported a position in Insulet in Q4 2022 and has held it in 14 quarters since.
  • NewEdge Advisors's Insulet position peaked at $970K in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.